Clinical Trial Update: Assessment of Residual Allergenicity of Ragweed Pollen Allergoid With Monophosphoryl Lipid A (MPL) Using Skin Prick Testing [Phase 1]

View source ↗

Summary

Phase 1 study assessing the residual allergenicity of a ragweed pollen allergoid formulated with Monophosphoryl Lipid A (MPL) using skin prick testing; study co…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Allergic Rhinitis

Drugs mentioned

• Ragweed Pollen Allergoid with Monophosphoryl Lipid A (MPL) (ragweed pollen allergoid with monophosphoryl lipid A)

Snippet

Sponsor: Allergy Therapeutics | Conditions: Type I Hypersensitivity | Phase 1 | Status: COMPLETED